Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 312

Smoking Cessation

NICE guideline [NG209] Tobacco: preventing uptake, promoting quitting and treating dependence. Last updated: Feb 2025.

NICE CKS Smoking cessation. Last revised: May 2025.

A section for smoking cessation intervention for pregnant patients has been added.

Date: 19/11/25

Guidelines

Smoking Cessation Interventions

Available interventions:

Category Specific intervention
Behavioural interventions
  • Behavioural support (individual and group)
  • Brief advice
Medicinally licensed products
  • Nicotine replacement therapy (gum / inhalator / lozenge / spray / sublingual tablet / transdermal patch)
  • Bupropion
  • Varenicline
  • Cytisinicline (cytisine)
Nicotine-containing e-cigarettes n/a
Allen Carr’s Easyway in-person group seminar n/a

Advice on nicotine-containing e-cigarettes:

  • E-cigarettes are not licensed medicines but are regulated by the Tobacco and Related Products Regulations (2016)
  • Not enough evidence to know whether there are long-term harms from e-cigarette use
  • Use of e-cigarettes is less likely to be substantially less harmful than smoking
  • Any smoking is harmful, so people who use e-cigarettes should stop smoking tobacco completely

Prescribing Information

NICE do not recommend any specific medications as 1st line, instead advises that the decision should be guided by 1) contraindications and adverse effects, 2) patient’s preference, 3) previous experience with smoking cessation drugs.

Drug MoA Contraindications Adverse effects
Nicotine replacement therapy Exogenous nicotine No specific contraindications
  • Headache and dizziness
  • Nausea and vomiting
  • Rash and urticaria
  • Palpitations
  • Hyperhidrosis
Bupropion Noradrenaline-dopamine reuptake inhibitor
  • <18 y/o
  • Current or history of seizures
  • Current of history of anorexia bulimia
  • History of bipolar disorder
  • CNS tumour
  • Severe hepatic cirrhosis
  • Acute alcohol or benzodiazepine withdrawal
  • Psychiatric side effects
    • Insomnia (very common)
    • Anxiety
    • Agitation
    • Depression
  • Neurological side effects
    • Tremor
    • Concentration disturbance
    • Headache and dizziness
  • Non-specific side effects
    • Dry mouth
    • Nausea and vomiting
    • Abdominal pain
    • Constipation
    • Fever
    • Rash, pruritus
Varenicline Nicotinic acetylcholine receptor partial agonist
  • <18 y/o
  • End-stage renal disease
  • Psychiatric side effects
    • Abnormal dreams
    • Insomnia
    • Suicidal thoughts, hallucinations, aggression (uncommon)
  • GI side effects
    • Nausea and vomiting
    • Constipation, diarrhoea
    • Abdominal distension and discomfort
    • Dyspepsia
    • Flatulence
    • Toothache
    • Dry mouth
  • Cardiac side effects
    • Myocardia infarction
    • Angina pectoris
    • Palpitations
Cytisinicline Nicotinic acetylcholine receptor partial agonist
  • <18 y/o or ≥66 y/o
  • Unstable angina / arrhythmias / recent myocardial infarction / recent stroke
  • Renal / hepatic impairment
  • Anxiety or mood alteration
  • Appetite change
  • Impaired concentration and fatigue
  • Constipation
  • Nausea and vomiting
  • Dizziness, drowsiness
  • Dry mouth
  • Headache
  • Myalgia

 

Drug Initiation timing Duration of treatment
Nicotine replacement therapy Start on quit date 8-12 weeks
Bupropion Start 1-2 weeks before quit date (i.e. start when the patient is still smoking) 7-9 weeks
Varenicline Start 1-2 weeks before quit date (i.e. start when the patient is still smoking) 12 weeks
Cytisinicline Start 5 days before quit date (i.e. start when the patient is still smoking) 25 days

Follow Up

Measure carbon monoxide level 4 weeks after quitting

  • ≤10 suggests the person is not smoking

Smoking Cessation Interventions in Pregnancy

Testing

Routine carbon monoxide testing (to assess the person’s exposure to tobacco smoke) should be offered to ALL pregnant women at:

  • First antenatal appointment, and
  • 36-week appointment

 

Carbon monoxide testing should be offered at ALL antenatal appointments if the patient:

  • Smokes, or
  • Are quitting, or
  • Used to smoke, or
  • Carbon monoxide ≥4 ppm at first antenatal appointment

Apart from smoking, there are other causes of elevated carbon monoxide levels:

  • 3-10 ppm = check for other sources of carbon monoxide (e.g. passive smoking, heating appliances, traffic emissions)
  • >10 ppm = possible carbon monoxide poisoning (contact Gas Emergency Line for gas safety advice) or the patient smokes (explore sensitively using a non-judgmental approach)

Referral

Referral to stop-smoking support during pregnancy is indicated if ANY of the following:

  • Carbon monoxide level ≥4 ppm
  • The patient smokes or stopped in the past 2 weeks

Management

1st line: refer to the local smoking cessation service for behavioural support

 

2nd line: nicotine replacement therapy

  • Advise that it is safe in pregnancy
  • Combination nicotine replacement therapy is most effective (e.g. a patch + a short-acting preparation)
  • Intermittent dose forms (e.g. gum and lozenges) are generally preferred over continuous dose forms (i.e. patches)

Do not offer varenicline / bupropion / cytisinicline during pregnancy / breastfeeding

Explain that it is the tar and carbon monoxide in tobacco smoke that cause the most harm to the baby (not nicotine), and that these are not present in NRT.

NICE also recommends monitoring smoking status regularly (to encourage patients to quit and as a way to provide positive feedback once an attempt has been made)

  • Carbon monoxide tests
  • Urine / saliva cotinine test (more accurate than carbon monoxide, as they can detect exposure over the past few days rather than hours)

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD